Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maike Voges

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Plos One|July 7, 2012
Extracellular IgC2 constant domains of CEACAMs mediate PI3K sensitivity during uptake of pathogensMaike Voges, Verena Bachmann, Jan Naujoks, et al.
BMC Microbiology|April 22, 2010
CEACAM1 recognition by bacterial pathogens is species-specificMaike Voges, Verena Bachmann, Robert Kammerer, et al.
The Journal of Biological Chemistry|January 11, 2011
Phosphatidylinositol 3'-kinase activity is critical for initiating the oxidative burst and bacterial destruction during CEACAM3-mediated phagocytosisAlexander Buntru, Kathrin Kopp, Maike Voges, et al.
Journal of Virology|August 19, 2011
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expressionJeanette Reiser, José Hurst, Maike Voges, et al.
BMC Infectious Diseases|July 25, 2016
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotideMaike Voges, Carola Schneider, Malte Sinn, et al.
Plos One|August 7, 2018
Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivoJulia S Czechowicz, Claus-Henning Nagel, Maike Voges, et al.
Plos One|June 25, 2016
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator SystemsJulia K Bialek, Gábor A Dunay, Maike Voges, et al.
Plos One|March 8, 2024
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1Niklas Beschorner, Paul Künzle, Maike Voges, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Plos One|July 7, 2012
Extracellular IgC2 constant domains of CEACAMs mediate PI3K sensitivity during uptake of pathogensMaike Voges, Verena Bachmann, Jan Naujoks, et al.
BMC Microbiology|April 22, 2010
CEACAM1 recognition by bacterial pathogens is species-specificMaike Voges, Verena Bachmann, Robert Kammerer, et al.
The Journal of Biological Chemistry|January 11, 2011
Phosphatidylinositol 3'-kinase activity is critical for initiating the oxidative burst and bacterial destruction during CEACAM3-mediated phagocytosisAlexander Buntru, Kathrin Kopp, Maike Voges, et al.
Journal of Virology|August 19, 2011
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expressionJeanette Reiser, José Hurst, Maike Voges, et al.
BMC Infectious Diseases|July 25, 2016
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex-forming oligonucleotideMaike Voges, Carola Schneider, Malte Sinn, et al.
Plos One|August 7, 2018
Interaction between the cellular E3 ubiquitin ligase SIAH-1 and the viral immediate-early protein ICP0 enables efficient replication of Herpes Simplex Virus type 2 in vivoJulia S Czechowicz, Claus-Henning Nagel, Maike Voges, et al.
Plos One|June 25, 2016
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator SystemsJulia K Bialek, Gábor A Dunay, Maike Voges, et al.
Plos One|March 8, 2024
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1Niklas Beschorner, Paul Künzle, Maike Voges, et al.
Pageof 1